Akums Inks Pact with Triple Hair Group, Canada for Treating Alopecia
Akums inks licensing pact with Triple Hair Group, Canada for patented topical solution targeting alopecia
Overview
Akums Drugs & Pharmaceuticals a CDMO (contract development and manufacturing organisation) has inked a strategic partnership with Triple Hair Group, a Canadian company specializing in the development of innovative treatments for androgenic alopecia. This is for the exclusive licensing of their patented topical formulation for the Indian market which combines three medicaments to combat alopecia, a common condition affecting millions in India and worldwide.
About Topical Solution & Its Working
The newly licensed topical solution is designed to provide a comprehensive approach to hair care.
It works to prevent hair fall, stimulate new hair growth, and enhance hair thickness and density, offering a one-stop solution for those battling hair thinning and baldness.
This cutting-edge formula promises a convenient and effective option for users who prefer topical treatments, with the potential to improve compliance and outcomes for individuals struggling with hair loss.
Words from the MD: Akums
Sanjeev Jain, managing director, Akums said, “The company’s collaboration with Triple Hair marks a significant step towards expanding our dermatology portfolio and providing innovative and effective solutions for hair care in the Indian market.”
Vision Behind Collaboration
This collaboration aligns with our vision of offering cutting-edge solutions that cater to the evolving needs of our customers.
This patented formulation is set to revolutionize the way alopecia is treated in India, and we are confident that this product will help many people regain their confidence and self-esteem, said Sandeep Jain, managing director, Akums.
Words from the CEO: Triple Hair
“One of the great advantages of this partnership is that Akums will be directly involved in the regulatory process, including an upcoming phase III clinical trial in India. We expect to start the process in the coming weeks so that we can commercialize Therapy-07 in India as soon as possible,” stated Jean-Philippe Gravel, CEO, Triple Hair.